NCCN Guidelines Insights: Cervical Cancer, Version 1.2020
Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Sarah Bean, Kristin Bradley, Susana M. Campos, Hye Sook Chon, Christina Chu, David E. Cohn, Marta A. Crispens, Shari Damast, Christine M. Fisher, Peter J. Frederick, David K. Gaffney, Robert Giuntoli, Ernest Han, Warner K. Huh, John R. Lurain, Andrea Mariani, David G. Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda N. Fader, Steven W. Remmenga, R. Kevin Reynolds, Rachel Sisodia, Todd Tillmanns, Stefanie Ueda, Renata R. Urban, Emily Wyse, Nicole R. McMillian, Angela D. Motter
Abstract
The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup, staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to first- and second-line systemic therapy recommendations for patients with recurrent or metastatic disease, and emerging evidence on a new histopathologic classification system for HPV-related endocervical adenocarcinoma.